GSK has committed $50 million in upfront capital and near-term milestones to secure a license to two cancer research foundation models from Noetik. San Francisco-based Noetik has used spatial biology ...
Noetik, an AI-native biotech company pioneering self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therapeutics, announced today a five-year strategic ...
31 January 2012 More than 28,000 visitors and participants from 132 countries to attend much-awaited event running from January 31 to February 2 GlaxoSmithKline (GSK) Consumer Healthcare has announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback